The State Commission of the Russian Federation for Testing and Protection of Selection Achievements (“FSBI Gossortkomissiya”) issued Endopharm a patent for a selection achievement - a new variety of soporific poppy (in agricultural practice - oilseed poppy) MARAL, entered in the State Register of Selection Achievements Authorized for use at the beginning of this year.
The MARAL variety has a low content of alkaloids, which makes the plants of this variety unattractive for illegal production and consumption of narcotic drugs.
At the same time, the alkaloid extraction technologies modernized and adapted by the scientific divisions of Endopharm make it possible to produce high-quality pharmaceutical substance morphine hydrochloride from low-alkaloid raw materials.
Currently, patients in Russia have access to the main line of drugs with INN morphine used in international practice, more than 90% of which are domestic. At the same time, the entire volume of active pharmaceutical ingredients necessary for their production is imported, which makes the issue of the availability of pain relief medicines for Russian patients dependent on the international market.
In order to ensure national sovereignty in this segment, the Ministry of Industry and Trade of Russia, together with Endopharm, by 2024 will implement a large-scale investment project to organize a full cycle of production of opium narcotic drugs in the Russian Federation.
In November 2021, a branch of Endopharm-Agro is being created in the Pochep district of the Bryansk region to solve the problem of providing the Pochep branch with raw materials for the production of active pharmaceutical ingredients of plant origin.
Thus, Endopharm is completing the formation of a technological complex as part of an agricultural subdivision for poppy cultivation, a branch for processing plant materials into active pharmaceutical ingredients, and two sites for the production of finished dosage forms.
The organization of the specified technological complex will make it possible by 2024 to get rid of import dependence in the availability of pain relief medicines and completely localize the production of opium narcotic drugs in Russia to ensure the drug security of our country.
Comment type is not specified in the component properties.